Skip to main content

Table 2 Availability of anti-malarials in the public sector, among all screened outlets

From: The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016

  Public Health Facilitya CHWb
% (95% CI) % (95% CI)
Any anti-malarial
 Total 91.8 (89.2, 93.8) 2.4 (0.9, 6.3)
 Endemic 99.0 (95.8, 99.8) 4.2 (1.0, 15.6)
 Endemic-prone 97.6 (91.9, 99.3) 3.5 (0.8, 14.9)
 Low-risk 81.0 (72.2, 87.5) 0.0 (–)
 Seasonal-transmission 91.5 (86.5, 94.7) 0.7 (0.2, 2.2)
QAACT
 Total 87.1 (83.0, 90.4) 2.4 (0.9, 6.3)
 Endemic 92.2 (77.8, 97.6) 4.2 (1.0, 15.6)
 Endemic-prone 93.5 (85.0, 97.3) 3.5 (0.8, 14.9)
 Low-risk 77.0 (66.1, 85.2) 0.0 (–)
 Seasonal-transmission 87.5 (80.1, 92.4) 0.7 (0.2, 2.2)
Non-QAACT
 Total 12.3 (7.9, 18.7) 0.1 (0.0, 0.3)
 Endemic 9.3 (3.4, 22.9) 0.1 (0.0, 0.7)
 Endemic-prone 10.7 (5.1, 20.8) 0.1 (0.0, 1.2)
 Low-risk 17.8 (7.2, 37.9) 0.0 (–)
 Seasonal-transmission 10.8 (4.2, 25.2) 0.0 (–)
SP
 Total 17.6 (13.7, 22.3) 0.0 (–)
 Endemic 70.0 (56.4, 80.8) 0.0 (–)
 Endemic-prone 0.4 (0.0, 3.2) 0.0 (–)
 Low-risk 0.1 (0.0, 0.6) 0.0 (–)
 Seasonal-transmission 0.0 (–) 0.0 (–)
Artesunate IV/IM
 Total 46.0 (39.7, 52.3) 0.0 (–)
 Endemic 59.8 (41.6, 75.7) 0.0 (–)
 Endemic-prone 63.9 (50.9, 75.2) 0.0 (–)
 Low-risk 16.0 (6.8, 33.4) 0.0 (–)
 Seasonal-transmission 48.9 (39.3, 58.7) 0.0 (–)
  1. aEndemic, N = 182; Endemic-prone, N = 246; Low-risk, N = 151; Seasonal-transmission, N = 217
  2. bEndemic, N = 682; Endemic-prone, N = 312; Low-risk, N = 316; Seasonal-transmission, N = 505